Certain differences between infections of mice with LCM and Tacaribe viruses were apparent. Tacaribe virus pathogenicity decreased with increasing mouse age, and earlier infection and a more prolonged course of ALS treatment than was needed for LCM virus were necessary to achieve increased survival. Histopathological changes observed in Tacaribe virus-infected control mice were focal choroiditis and focal cerebellar necrosis; these changes were not seen in asymptomic infected mice during the period of transient protection by ALS.
On the basis of common physicochemical, morphological, and antigenic relationships (5, 21, 26) , a new virus taxonomic group, the arenoviruses, has been established (25) ; viruses of this group include lymphocytic choriomeningitis (LCM), Tacaribe, Junin, Machupo, Lassa, and several other agents. Because of its biological behavior, LCM virus has long been of interest as a model for chronic viral carrier states and viral-induced immunopathogenic disease. Previous studies have demonstrated that antilymphocyte serum (ALS) not only prevented the mortality associated with LCM infection of adult mice (7, 10, 18) but also permitted the development of the viral carrier state in infant animals at an older age than was normally possible (9) .
Similar biological properties and animal pathogenesis may be characteristic of all members of the arenovirus group. Like LCM virus, Machupo virus has been demonstrated to induce a chronic viral carrier state in its natural rodent host, Calomys callosus (13) . In a further parallel, Junin virus immunopathogencity for mice was prevented by neonatal thymectomy (30) . To further examine similarities in the biological I Present address: Oncology Division, The Johns Hopkins School ofMedicine, Baltimore City Hospital, Baltimore, Md. 21224. characteristics of the arenoviruses, we have studied the effects of ALS on infection of suckling mice (SM) with Tacaribe virus, a virus initially isolated from Artebius bats (6) , which is pathogenic for both suckling and adult mice (6) and which multiplies predominantly in the brain (8 Animals. Swiss mice of the ICR strain, free from observable intercurrent infections, were used for all studies.
Antilymphocyte serum. Horse antimouse thymocyte serum (HAMT; lot no. 9716) was obtained from Robbin Laboratories, Chapel Hill, N.C. It was determined by them to be effective in suppressing the rejection by C57BL1O/ScSn mice of a 3-methylcholanthrene induced sarcoma, differing at the H-2 locus from its donor host, a B1OD2 mouse. The HAMT administered intraperitoneally (ip) to adult ALS AND TACARIBE VIRUS INFECTION mice in our laboratory depressed the peripheral mononuclear count 70 to 80%. It was also effective, as shown below, in preventing signs of LCM infection of 1-week-old mice. This assay has proved reliable in our laboratory as a measure of cellular immune suppression (9) . Neither HAMT nor normal horse serum (NHS; Grand Island Biological Co., Grand Island, N.Y.) was toxic upon repeated administration: neonatal mice given 0.9 ml by the ip route in 13 divided doses over 30 days from birth were not runted or otherwise clinically distinguishable from uninoculated controls during development or at 8 weeks of age. During the period of serum administration to this uninfected control group, none of 15 animals given HAMT and two of 19 given NHS died. The frequency of HAMT administration in relation to time of virus inoculation varied in different experiments, as indicated below, but HAMT was always given ip in 0.05-ml doses.
Virus titrations. Titrations of LCM and Tacaribe viruses were performed in SM 1 to 3 days old; 0.02 ml of virus dilutions was given ic. The LD50 end points were determined by the method of Karber (14) . No difficulty was encountered in determining end points for Tacaribe virus in mouse titrations.
Titrations of Tacaribe virus in serum and brain tissue of infected animals were performed on pooled material from three animals. Serial dilutions were prepared in Eagles minimal essential growth medium containing 10% newborn calf serum.
Complement-fixation tests. Complement-fixation (CF) tests on serum were performed using the LBCF microtechnique against mouse brain antigen extracted by Veronal-buffered diluent (4 (Fig. 2A) . There was a 10-to 12-day delay of the first death, of the 50' c survival time, and of the last virus death. The weights of HAMT-treated animals were not significantly different from those of NHS controls. Extending HAMT treatment of surviving animals beyond day 16 (0.1 ml of HAMT every 3 days to day 30) resulted in a simrilar overall effect (Fig. 2B) except that four out of 21 mice survived more than 30 days. Of these four survivors, one (SI) died on day 35 and had a large subhepatic abscess on autopsy; a second (S2) died on day 37 and had a peritoneal abscess; and a third (S3) was found cannibalized on day 39. The fourth (S4) was sacrificed on day 70; it showed no clinical evidence of infection and was of normal weight.
Virus titrations. Littermates of the mouse group which received virus on day 0 and HAMT or NHS for 30 days (Fig. 2B ) were sacrificed at 2-day intervals to day 12, and littermates of the HAMT group were sacrificed on day 19 for virus titration. Tacaribe virus titers in serum and brain of both the T\ HS-and HAMT-treated groups were similar at each sample time (Fig. 3) There were, however, quantitative differences in the effect of ALS on Tacaribe and LCM infections. Thus, a course of ALS treatment resulted in only a short, although significant, pro-14 16 18 LendCyMts or 1 yr in blood and urine after ip infection of lesion of the infant and some adult C. callosus (13 (Fig. 2) . The multiplication of Tacaribe virus was not suppressed in this group; virus growth curves in serum and brain of control and ALS-treated groups were similar (Fig. 3) (20) to produce cerebellar necrosis in neonatally infected rats.
Furthermore, Tamiami, another arenovirus, has been shown to produce a similar lesion in mice (3) .
A complex balance of virus-host interactions seems to determine the outcome of arenovirus infection. Absence of both cellular and humoral immune reactivity produces a state of prolonged survival and persistent viral carriage in the newborn mouse infected with LCM (11, 28) or in C. callosus infected with Machupo virus (13) . Such an animal probably represents a reservoir host. Pathological changes, which develop most rapidly in the unnatural host, result from an intense cellular immune response (10, 11, 24) and the development of complement-mediated immune complex disease (22, 23 (30) . Pathogenicity can also be influenced by immunological maturity of the host (11) and possibly the degree of virus-mediated immune suppression (19) .
Overcoming an arenovirus infection probably depends upon the strength of the neutralizing antibody response (29) , upon cell-mediated viral elimination (17) , and upon undefined host genetic defenses (11, 22, 29 
